Patents by Inventor Hans U. Gubler

Hans U. Gubler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organic compounds
    Patent number: 5096921
    Abstract: .alpha.-[10-oxy-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene]-carboxyli c acids, or physiologically-hydrolysable and -acceptable esters or pharmaceutically acceptable salts thereof are useful for effecting monokine inhibition, in particular interleukin-1 release or secretion inhibition, as a therapeutic means other than anti-inflammatory or anti-pyretic means.
    Type: Grant
    Filed: August 2, 1990
    Date of Patent: March 17, 1992
    Assignee: Sandoz Ltd.
    Inventors: Pietro Bollinger, Hans U. Gubler, Jorg Schnyder
  • Treating tissue calcium depletion or degenerative processes in bone or cartilage
    Patent number: 4956381
    Abstract: .alpha.-[10-oxy-4H-benzo[4,5]cycloheptal[1,2-b]thiophen-4-ylidene]-carboxyl ic acids, or physiologically-hydrolysable and -acceptable esters or pharmaceutically acceptable salts thereof are useful for effecting monokine inhibition, in particular interleukin-1 release or secretion inhibition, as a therapeutic means other than anti-inflammatory or anti-pyretic means.
    Type: Grant
    Filed: October 25, 1988
    Date of Patent: September 11, 1990
    Assignee: Sandoz Ltd.
    Inventors: Pietro Bollinger, Hans U. Gubler, Jorg Schnyder